This research represents an important step forward in our scientific development pipeline. These AI/ML tools strengthen AIM’s foundation and open the door to future applications.” — Steve Rowley, Vice ...
ETS is the Third Product Using CrossGlide™ Technology Aimed at Modernizing the Way Gynecological Procedures are Performed in Physicians' Offices SAN FRANCISCO, Aug. 22, 2019 /PRNewswire/ -- CrossBay ...
Accumulating evidence suggests that many ovarian high-grade serous carcinomas (HGSCs) originate in the fallopian tube. Malignant cells shed by tubal lesions can be detected by examination of ...
SAN FRANCISCO--(BUSINESS WIRE)--CrossBay Medical, Inc., a health technology company focused on improving the delivery of women’s healthcare, today announced it has received clearance from the Food and ...
Phase I Study of BMS-214662, a Farnesyl Transferase Inhibitor in Patients With Acute Leukemias and High-Risk Myelodysplastic Syndromes Forty-four patients with endometrial (n = 15) or cervical (n = 29 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results